Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.

被引：0
|
作者：
Tanaka, Y
Tokunaga, M
Kawabata, D
Imura, Y
Fujii, T
Nawata, M
Tsujimura, S
Nakayamada, S
Mimoro, T
Saito, K
机构：
[1] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka 807, Japan
[2] Kyoto Univ, Grad Sch Med, Kyoto, Japan
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S191 / S191
页数：1
相关论文
共 50 条
  • [1] Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system
    Tokunaga, Mikiko
    Saito, Kazuyoshi
    Kawabata, Daisuke
    Imura, Yoshitaka
    Fujii, Takao
    Nakayamada, Shingo
    Tsujimura, Shizuyo
    Nawata, Masao
    Iwata, Shigeru
    Azuma, Taeko
    Mimori, Tsuneyo
    Tanaka, Yoshiya
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (04) : 470 - 475
  • [2] Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus
    Iwata, S.
    Saito, K.
    Hirata, S.
    Ohkubo, N.
    Nakayamada, S.
    Nakano, K.
    Hanami, K.
    Kubo, S.
    Miyagawa, I.
    Yoshikawa, M.
    Miyazaki, Y.
    Yoshinari, H.
    Tanaka, Y.
    LUPUS, 2018, 27 (05) : 802 - 811
  • [3] A pilot study of rituximab (anti-CD20) for refractory systemic lupus erythematosus
    Tanaka, Y.
    Tokunaga, M.
    Nawata, M.
    Nakayamada, S.
    Sawamukai, N.
    Saito, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 360 - 361
  • [4] Refractory Systemic Lupus Erythematosus Involving The Central Nervous System Responsive To Rituximab Treatment
    Yun, D. J.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 955 - 956
  • [5] Long-term benefits of rituximab (anti-CD20) for refractory systemic lupus erythematosus
    Tanaka, Y.
    Tokunaga, M.
    Nawata, M.
    Suzuki, K.
    Iwata, S.
    Yamaoka, K.
    Nakayamada, S.
    Saito, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 483 - 483
  • [6] Successful treatment with anti-CD20 monoclonal antibody (rituximab) of life-threatening refractory systemic lupus erythematosus with renal and central nervous system involvement
    Saito, K
    Nawata, M
    Nakayamada, S
    Tokunaga, M
    Tsukada, J
    Tanaka, Y
    LUPUS, 2003, 12 (10) : 798 - 800
  • [7] Efficacy of Belimumab for refractory systemic lupus erythematosus (SLE) involving the central nervous system
    Cheng, Hao
    Zhao, Chen-sheng
    Yan, Cheng-lan
    Gao, Chong
    Wen, Hong-yan
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 92 : 117 - 120
  • [8] Anti-CD20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus
    ten Cate, R
    Smiers, FJ
    Bredius, RGM
    Lankester, AC
    van Suijlekom-Smit, LWA
    Huizinga, TW
    Egeler, RM
    RHEUMATOLOGY, 2004, 43 (02) : 244 - 245
  • [9] Rituximab (anti-CD20 monoclonal antibody) for refractory systemic lupus erythematosus.: Report of one case
    Sabugo, F
    Llanos, C
    Soto, L
    Gutiérrez, J
    Cuchacovich, M
    REVISTA MEDICA DE CHILE, 2005, 133 (06) : 681 - 684
  • [10] Anti-CD20 therapy for inducing and maintaining remission in refractory systemic lupus erythematosus
    Chehab, G.
    Sander, O.
    Fischer-Betz, R.
    Schneider, M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 (04): : 328 - +
12345